
Join to view full profile
1 Medical Center DrDhmc Department Of MedicineLebanon, NH 03756
Phone+1 603-650-6345
Dr. Dmitrovsky is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1983 - 1987
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1980 - 1983
Weill Cornell MedicineClass of 1980
Certifications & Licensure
NH State Medical License 1998 - 2028
TX State Medical License 2016 - 2019
NY State Medical License 1981 - 1999
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1994
Publications & Presentations
PubMed
- 2 citationsCDK2 inhibition produces a persistent population of polyploid cancer cells.Liliya Tyutyunyk-Massey, Zibo Chen, Xiuxia Liu, Masanori Kawakami, Adam Harned
JCI Insight. 2025-05-22 - 2 citationsGlycemic control in diabetic patients improved overall lung cancer survival across diverse populations.Wayne Y Wu, Brian Luke, Xiao-Cheng Wu, J Jack Lee, Yong Yi
JNCI Cancer Spectrum. 2024-09-02 - 5 citationsCDK2 inhibition disorders centrosome stoichiometry and alters cellular outcomes in aneuploid cancer cells.Zibo Chen, Xi Liu, Masanori Kawakami, Xiuxia Liu, Allison Baker
Cancer Biology & Therapy. 2023-12-31
Press Mentions
Ethan DmitrovskyJuly 28th, 2022
A Close Brush with Gun Violence Made Me Think About How to Confront an Epidemic During a PandemicAugust 1st, 2021
Lowy: “Our Patients Are Counting on Us, and We Must Not Let Them Down”April 17th, 2020
Grant Support
- DEVELOPMENT OF TARGET CHARACTERIZATION METHODS FOR NOVEL CANCER MARKERSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2027
- DEVELOPMENT OF TARGET CHARACTERIZATION METHODS FOR NOVEL CANCER MARKERSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2027
- DEVELOPMENT OF TARGET CHARACTERIZATION METHODS FOR NOVEL CANCER MARKERSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2027
- DEVELOPMENT OF TARGET CHARACTERIZATION METHODS FOR NOVEL CANCER MARKERSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2027
- DEVELOPMENT OF TARGET CHARACTERIZATION METHODS FOR NOVEL CANCER MARKERSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2027
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









